loadpatents
name:-0.025537014007568
name:-0.021537065505981
name:-0.00047421455383301
BOURGUIGNON; Jean-Jacques Patent Filings

BOURGUIGNON; Jean-Jacques

Patent Applications and Registrations

Patent applications and USPTO patent grants for BOURGUIGNON; Jean-Jacques.The latest application filed is for "compounds and compositions for the treatment of pain".

Company Profile
0.18.16
  • BOURGUIGNON; Jean-Jacques - Illkirch-Graffenstaden FR
  • Bourguignon; Jean-Jacques - Illkirch FR
  • Bourguignon; Jean-Jacques - Hipsheim FR
  • Bourguignon; Jean-Jacques - IIIkirch Graffenstaden FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds And Compositions For The Treatment Of Pain
App 20210221784 - SCHMITT; Martine ;   et al.
2021-07-22
Pyridazine compounds, compositions and methods
Grant 9,663,493 - Watterson , et al. May 30, 2
2017-05-30
Pyridazine compounds, compositions and methods
Grant 9,527,819 - Watterson , et al. December 27, 2
2016-12-27
Pyridazine Compounds, Compositions And Methods
App 20160326139 - WATTERSON; D. Martin ;   et al.
2016-11-10
Pyridazine Compounds, Compositions And Methods
App 20150175555 - WATTERSON; D. Martin ;   et al.
2015-06-25
Pyridazine compounds, compositions and methods
Grant 8,933,076 - Watterson , et al. January 13, 2
2015-01-13
Pyridazine compounds, compositions and methods
Grant 8,367,672 - Watterson , et al. February 5, 2
2013-02-05
Pyridazine Compounds, Compositions And Methods
App 20120245125 - Watterson; D. Martin ;   et al.
2012-09-27
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
Grant 8,088,774 - Watterson , et al. January 3, 2
2012-01-03
Pyridazine compounds and methods
Grant 8,063,047 - Watterson , et al. November 22, 2
2011-11-22
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
Grant 7,888,357 - Watterson , et al. February 15, 2
2011-02-15
Anti-Inflammatory And Protein Kinase Inhibitor Compositions And Related Methods For Downregulation Of Detrimental Cellular Responses And Inhibition Of Cell Death
App 20100317665 - Watterson; D.M. ;   et al.
2010-12-16
Inhibitors of Phosphodiesterase Types 1 To 5 Based on Dioclein, Floranol, and Analogs Thereof
App 20090270495 - Soares Lemos; Virginia ;   et al.
2009-10-29
Use of Adenine-Derived Compounds for the Treatment of Lupus
App 20090221613 - Lugnier; Claire Renee Jeanne ;   et al.
2009-09-03
Pyridazine Compounds And Methods
App 20090029985 - Watterson; Martin ;   et al.
2009-01-29
Pyridazine Compounds, Compositions and Methods
App 20080318899 - Watterson; Martin ;   et al.
2008-12-25
Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
Grant 7,250,410 - Bourguignon , et al. July 31, 2
2007-07-31
Method for isolating an allosteric effector of a receptor
App 20060194259 - Galzi; Jean-Luc ;   et al.
2006-08-31
Compositions derived from quinoline and quinoxaline, preparation and use thereof
App 20060183909 - Schmitt; Martine ;   et al.
2006-08-17
Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
App 20060128695 - Bourguignon; Jean-Jacques ;   et al.
2006-06-15
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
App 20060073472 - Watterson; D. M. ;   et al.
2006-04-06
Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
Grant 6,972,343 - Vial , et al. December 6, 2
2005-12-06
Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
App 20050113366 - Bourguignon, Jean-Jacques ;   et al.
2005-05-26
Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
App 20040152888 - Bourguignon, Jean-Jacques ;   et al.
2004-08-05
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
App 20030176437 - Watterson, D.M. ;   et al.
2003-09-18
Pyridazine derivatives
Grant 5,656,631 - Boigegrain , et al. August 12, 1
1997-08-12
Pyridazine derivatives
Grant 5,461,053 - Boigegrain , et al. * October 24, 1
1995-10-24
3-(N-azabicycloalkyl)aminopyridazine derivatives and pharmaceutical compositions in which they are present
Grant 5,276,036 - Bourguignon , et al. January 4, 1
1994-01-04
Compounds having an aryltriazine structure
Grant 5,254,548 - Wermuth , et al. October 19, 1
1993-10-19
Tricyclic cholinergic receptor agonists
Grant 4,983,603 - Wermuth , et al. January 8, 1
1991-01-08
Novel tricyclic derivatives which are agonists of cholinergic receptors, and drugs in which they are present
Grant 4,977,152 - Biziere , et al. December 11, 1
1990-12-11
Imidazo[1,2-]pyridazines for cortical cholinergic deficiencies
Grant 4,910,199 - Bourguignon , et al. March 20, 1
1990-03-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed